A Comprehensive Cocrystal Screening Study of Chlorothiazide

被引:27
作者
Aljohani, Marwah [1 ]
Pallipurath, Anuradha R. [1 ]
McArdle, Patrick [1 ]
Erxleben, Andrea [1 ]
机构
[1] Natl Univ Ireland, Sch Chem, Galway, Ireland
基金
爱尔兰科学基金会;
关键词
PHARMACEUTICAL COCRYSTALS; CARBOXYLIC-ACIDS; SOLUBILITY; CRYSTAL; SALT; BIOAVAILABILITY; POLYMORPHS; SYNTHONS;
D O I
10.1021/acs.cgd.7b00745
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cocrystal formation of chlorothiazide (ctz) was screened with a variety of coformers with carboxyl, amide, hydroxyl, sulfonamide, pyridine, amidine, and amine functional groups. New cocrystals with acetamide (aca), benzamide (bza), propionamide (ppa), caprolactam (cap), carbamazepine (cbz), nicotinamide (nia), isonicotinamide (ina), hexamethylenetetramine (hma), 4,4'-bipyridine (bipy), 1,2-di(4-pyridyl)ethylene (ebipy), 2-hydroxypyridine (hyp), 1,3-di(4-pyridyl)propane (pbipy) and pyrazine (pyr) as well as a benzamidinium (bzamH(+)) salt were obtained by mechanical grinding and liquid-assisted grinding and identified by powder X-ray diffraction. The structures of ctz-bza, ctz-cbz, ctz-ina, ctz-nia, ctz-hma, ctz-bipy, ctz-ebipy, ctzpbipy, and (bzamH(+)) (ctz(-)) were determined by single-crystal X-ray diffraction. Analysis of the hydrogen bonding motifs showed that in all cocrystal structures except for ctz-bipy, the NHsuifonamide center dot center dot center dot N (SO2)=C catemer synthon of ctz form I is replaced by ctz-coformer heterosynthons. The dissolution behavior and relationship between dissolution rate, packing index, and lattice energy of the cocrystals is described. To understand why no cocrystals with carboxylic acids formed, a motif search of the Cambridge Structural Database (CSD) was carried out.
引用
收藏
页码:5223 / 5232
页数:10
相关论文
共 36 条
[1]   Hydrogen bonding in sulfonamides [J].
Adsmond, DA ;
Grant, DJW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (12) :2058-2077
[2]   Cocrystal and Salt Forms of Furosemide: Solubility and Diffusion Variations [J].
Banik, Manas ;
Gopi, Shanmukha Prasad ;
Ganguly, Somnath ;
Desiraju, Gautam R. .
CRYSTAL GROWTH & DESIGN, 2016, 16 (09) :5418-5428
[3]   Pharmaceutical co-crystals - are we there yet? [J].
Blagden, N. ;
Colesb, S. J. ;
Berry, D. J. .
CRYSTENGCOMM, 2014, 16 (26) :5753-5761
[4]   Pharmaceutical cocrystals: walking the talk [J].
Bolla, Geetha ;
Nangia, Ashwini .
CHEMICAL COMMUNICATIONS, 2016, 52 (54) :8342-8360
[5]   Celecoxib cocrystal polymorphs with cyclic amides: synthons of a sulfonamide drug with carboxamide coformers [J].
Bolla, Geetha ;
Mittapalli, Sudhir ;
Nangia, Ashwini .
CRYSTENGCOMM, 2014, 16 (01) :24-27
[6]   New software for searching the Cambridge Structural Database and visualizing crystal structures [J].
Bruno, IJ ;
Cole, JC ;
Edgington, PR ;
Kessler, M ;
Macrae, CF ;
McCabe, P ;
Pearson, J ;
Taylor, R .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2002, 58 :389-397
[7]   Coformer Selection in Pharmaceutical Cocrystal Development: a Case Study of a Meloxicam Aspirin Cocrystal That Exhibits Enhanced Solubility and Pharmacokinetics [J].
Cheney, Miranda L. ;
Weyna, David R. ;
Shan, Ning ;
Hanna, Mazen ;
Wojtas, Lukasz ;
Zaworotko, Michael J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (06) :2172-2181
[8]   Thiazide Diuretics: 50 Years and Beyond [J].
Ernst, Michael E. ;
Grimm, Richard H., Jr. .
CURRENT HYPERTENSION REVIEWS, 2008, 4 (04) :256-265
[9]   Powder study of chlorothiazide N,N-dimethyl-formamide solvate [J].
Fernandes, P ;
Florence, AJ ;
Shankland, K ;
Shankland, N ;
Johnston, A .
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2006, 62 :O2216-O2218
[10]   Calculation of lattice energies of organic crystals: the PIXEL integration method in comparison with more traditional methods [J].
Gavezzotti, A .
ZEITSCHRIFT FUR KRISTALLOGRAPHIE, 2005, 220 (5-6) :499-510